Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes

European Journal of Endocrinology

Volumn 143, Issue 4, 2000, Pages 505-510

  Ekman, B ^a   Nystrom, F ^a   Arnqvist, H J ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; SOMATOMEDIN C;

ADULT; AGE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES CONTROL; DISEASE DURATION; DOSE RESPONSE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; SEX DIFFERENCE;

EID: 0033780678     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1430505     Document Type: Article

References (41)

1. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors
2. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion
3. The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver
4. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes
5. Metabolic actions of growth hormone in man
6. Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3
7. Insulin-like growth factor-I is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes
8. Plasma somatomedins, endogenous insulin secretion, and growth in transient neonatal diabetes mellitus
9. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes
10. Effect of insulin on the insulin-like growth factor system in children with new-onset insulin-dependent diabetes mellitus
11. IGF-I and diabetes in adolescence
12. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients
13. Serum insulin-like growth factor I levels in adult diabetic patients: The effect of age
14. Is insulin-like growth factor I associated with diabetic retinopathy?
15. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus
16. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment
17. Determinants of growth in diabetic pubertal subjects
18. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: Influence of diabetes control and intraportal insulin infusion
19. Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus
20. Effect of intraperitoneal insulin delivery on growth hormone binding protein, insulin-like growth factor (IGF)-I, and IGF-binding protein-3 in IDDM
21. Free insulin profiles during intensive treatment with biosynthetic human insulin
22. Natural course of growth hormone hypersecretion in insulin-dependent diabetes mellitus
23. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects
24. Serum leptin concentrations in a normal population and in GH deficiency: Negative correlation with testosterone in men and effects of GH treatment
25. Effects of age, duration and treatment of insulin-dependent diabetes mellitus on residual beta-cell function: Observations during eligibility testing for the Diabetes Control and Complications Trial (DCCT)
26. Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy
27. Circulating insulin-like growth factor I in type 1 (insulin-dependent) diabetic patients with retinopathy
28. Population-based reference values for IGF-I and IGF-binding protein-1: Relations with metabolic and anthropometric variables
29. Serum insulin-like growth factor I in a random population sample of men and women: Relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin
30. Serum levels of insulin-like growth factor (IGF) and IGF binding protein in insulin-dependent diabetics during an episode of severe metabolic decompensation and the recovery phase
31. Nutrition and somatomedin. XVII. Circulating somatomedin C during treatment of diabetic ketoacidosis
32. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus
33. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: Relationship with increased urinary excretion of IGFBP-3 18kD N-terminal fragment
34. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity
35. rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM
36. Adult growth hormone deficiency
37. Limited joint mobility in childhood diabetes mellitus indicates increased risk for microvascular disease
38. Isokinetic muscle strength in long-term IDDM patients in relation to diabetic complications
39. Hand abnormalities are strongly associated with the duration of diabetes mellitus
40. Diabetes mellitus and the incidence of hip fracture: Results from the Nord-Trondelag Health Survey